➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Moodys
Johnson and Johnson
Dow
Harvard Business School
Boehringer Ingelheim
Express Scripts

Last Updated: February 28, 2021

DrugPatentWatch Database Preview

Pralsetinib - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic sources for pralsetinib and what is the scope of patent protection?

Pralsetinib is the generic ingredient in one branded drug marketed by Blueprint Medicines and is included in one NDA. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Pralsetinib has twenty patent family members in nineteen countries.

Summary for pralsetinib
International Patents:20
US Patents:1
Tradenames:1
Applicants:1
NDAs:1
Bulk Api Vendors: 21
Clinical Trials: 1
Patent Applications: 18
DailyMed Link:pralsetinib at DailyMed
Recent Clinical Trials for pralsetinib

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Blueprint Medicines CorporationPhase 3

See all pralsetinib clinical trials

US Patents and Regulatory Information for pralsetinib

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Blueprint Medicines GAVRETO pralsetinib CAPSULE;ORAL 213721-001 Sep 4, 2020 RX Yes Yes   Start Trial   Start Trial   Start Trial
Blueprint Medicines GAVRETO pralsetinib CAPSULE;ORAL 213721-001 Sep 4, 2020 RX Yes Yes   Start Trial   Start Trial   Start Trial
Blueprint Medicines GAVRETO pralsetinib CAPSULE;ORAL 213721-001 Sep 4, 2020 RX Yes Yes   Start Trial   Start Trial Y Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
McKesson
Harvard Business School
Merck
Moodys
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.